ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

FasL-Presenting PEG Microgels Supports Sustained Graft Survival in Nonhuman Primates in the Absence of Continuous Immunosuppression

E. S. Yolcu1, J. Lei2, M. M. Coronel3, H. Deng4, Z. Yang4, A. Zhang4, T. Chen5, K. Lee4, C. Peters4, I. Rosales4, Z. Wang4, J. Markmann4, A. Garcia3, H. Shirwan1

1University of Missouri at Columbia, Columbia, MO, 2Surgery, Mass General, Boston, MA, 3Georgia Institute of Technology, Atlanta, GA, 4Massachusetts General Hospital, Boston, MA, 5Xiamen University Medical School, Xiamen, China

Meeting: 2022 American Transplant Congress

Abstract number: 174

Keywords: Apoptosis, Fas ligand, Islets, Tolerance

Topic: Basic Science » Basic Science » 12 - Immunosuppression & Tolerance: Preclinical & Translational Studies

Session Information

Session Name: Immunosuppression and Tolerance: Preclinical and Translational Studies

Session Type: Rapid Fire Oral Abstract

Date: Sunday, June 5, 2022

Session Time: 5:30pm-7:00pm

 Presentation Time: 6:40pm-6:50pm

Location: Hynes Ballroom A

*Purpose: Broad application of allogeneic islets for T1D treatment is curtailed by the use of chronic immunosuppression to control rejection. Teff cells are the major culprit of rejection and become sensitive to Fas-mediated apoptosis upon repeated engagement with alloantigens. We have previously reported the efficacy of PEG microgels presenting a novel form of FasL (SA-FasL) in inducing localized tolerance in allogeneic rodents. We herein demonstrate the efficacy of this approach in achieving sustained survival in an allogeneic NHP model.

*Methods: PEG microgels fabricated to display biotin on their surface were engineered for positional display of SA-FasL protein on the surface. SA-FasL presenting microgels were co-transplanted at 2:1 PEG:islet ratio into the omentum of STZ-diabetic allogeneic cynomolgus monkeys. PEG without SA-FasL co-transplanted with islets served as controls. Recipients were kept on a 3-month rapamycin regimen as the only maintenance therapy. Animals were monitored for graft survival for 6 months and subjected to IVGTT and surgical removal of the graft to assess function.

*Results: PEG-SA-FasL supported sustained graft survival in all 4 animals for a ~180-day observation period. In marked contrast, acute rejection was observed in 3 controls with PEG microgels without SA-FasL under the same rapamycin regimen. Graft recipients promptly achieved excellent glycemic control with normal fasting BGs. IVGTTs performed at 3- and 6-month post-transplantation revealed excellent islet function comparable to naive animals. Surgical removal of the transplant resulted in prompt hyperglycemia, demonstrating graft function, which was further confirmed by fasting and stimulated insulin and c-peptide levels. Graft survival was associated with increased number of T regulatory cells in the graft site.

*Conclusions: Immunomodulation with PEG-SA-FasL results in sustained allogeneic islet graft survival in a NHP model in the absence of chronic immunosuppression. PEG-SA-FasL as an off-the-shelf product presents a novel approach with considerable translational potential for the treatment of type 1 diabetes. Funded by JDRF (2-SRA-2016-271-S-B) and NIH (U01 AI132817).

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Yolcu ES, Lei J, Coronel MM, Deng H, Yang Z, Zhang A, Chen T, Lee K, Peters C, Rosales I, Wang Z, Markmann J, Garcia A, Shirwan H. FasL-Presenting PEG Microgels Supports Sustained Graft Survival in Nonhuman Primates in the Absence of Continuous Immunosuppression [abstract]. Am J Transplant. 2022; 22 (suppl 3). https://atcmeetingabstracts.com/abstract/fasl-presenting-peg-microgels-supports-sustained-graft-survival-in-nonhuman-primates-in-the-absence-of-continuous-immunosuppression/. Accessed March 26, 2023.

« Back to 2022 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2023 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences